Louvaris Z, Kortianou EA, Spetsioti S, Vasilopoulou M, Nasis I, Asimakos A, Zakynthinos S, Vogiatzis I. Intensity of daily physical activity is associated with central hemodynamic and leg muscle oxygen availability in COPD. J Appl Physiol 115: 794 -802, 2013. First published July 11, 2013 doi:10.1152/japplphysiol.00379.2013.-In chronic obstructive pulmonary disease (COPD), daily physical activity is reported to be adversely associated with the magnitude of exerciseinduced dynamic hyperinflation and peripheral muscle weakness. There is limited evidence whether central hemodynamic, oxygen transport, and peripheral muscle oxygenation capacities also contribute to reduced daily physical activity. Nineteen patients with COPD (FEV1, 48 Ϯ 14% predicted) underwent a treadmill walking test at a speed corresponding to the individual patient's mean walking intensity, captured by a triaxial accelerometer during a preceding 7-day period. During the indoor treadmill test, the individual patient mean walking intensity (range, 1.5 to 2.3 m/s 2 ) was significantly correlated with changes from baseline in cardiac output recorded by impedance cardiography (range, 1.2 to 4.2 L/min; r ϭ 0.73), systemic vascular conductance (range, 7.9 to 33.7 ml·min Ϫ1 ·mmHg Ϫ1 ; r ϭ 0.77), systemic oxygen delivery estimated from cardiac output and arterial pulse-oxymetry saturation (range, 0.15 to 0.99 L/min; r ϭ 0.70), arterio-venous oxygen content difference calculated from oxygen uptake and cardiac output (range, 3.7 to 11.8 mlO 2/100 ml; r ϭ Ϫ0.73), and quadriceps muscle fractional oxygen saturation assessed by near-infrared spectrometry (range, Ϫ6 to 23%; r ϭ 0.77). In addition, mean walking intensity significantly correlated with the quadriceps muscle force adjusted for body weight (range, 0.28 to 0.60; r ϭ 0.74) and the ratio of minute ventilation over maximal voluntary ventilation (range, 38 to 89%, r ϭ Ϫ0.58). In COPD, in addition to ventilatory limitations and peripheral muscle weakness, intensity of daily physical activity is associated with both central hemodynamic and peripheral muscle oxygenation capacities regulating the adequacy of matching peripheral muscle oxygen availability by systemic oxygen transport. activity monitoring; chronic obstructive pulmonary disease; nearinfrared spectroscopy; quadriceps muscle oxygenation; walking intensity IN PATIENTS WITH CHRONIC OBSTRUCTIVE pulmonary disease (COPD), daily physical activity is reduced compared with that in healthy age-matched individuals (6). Furthermore, it is well documented that reduced levels of physical activity in patients with COPD are associated with a faster rate of disease progression, greater systemic inflammation, and increased rates of hospital admission and mortality (16, 17, 49) .
greater systemic inflammation, and increased rates of hospital admission and mortality (16, 17, 49) .
Daily physical activity can be defined as the actual level of physical performance an individual adopts in daily living (25) . Physical activity can be directly monitored in patients with COPD by validated activity monitors for specific periods of time, typically ranging from 2 to 7 days, and can be described by dimensions such as frequency, duration, intensity, and type of physical activity (7, 33, 40, 42, 44) . In this context, numerous studies have documented profound reductions in the intensity of daily physical activity in patients with COPD compared with age-matched healthy individuals (10, 21, 34, 48) .
Importantly, reduced physical activity levels in people with COPD have been shown to be associated with a number of physiological limitations. A study by Garcia-Rio and colleagues (18) recently revealed that daily physical activity is mainly associated with the degree of exercise-induced dynamic lung hyperinflation. Besides dynamic lung hyperinflation, physical performance is also significantly associated with other indices, indicating the magnitude of pulmonary dysfunction (18) . In addition, both physical activity and functional capacity are associated with the extent of peripheral muscle weakness and dysfunction across GOLD (Global Initiative for Chronic Obstructive Lung Diseases) stages II-IV (39, 47) .
Moreover, physical activity in COPD may be affected by left cardiac dysfunction (49) , and there is a great deal of evidence indicating that exercise capacity in these patients is also restricted by a combination of factors that limit oxygen transport and utilization by the peripheral muscles (1, 46) . However, currently unknown is the extent to which limitations in central hemodynamic, oxygen transport, and peripheral muscle oxygen availability are associated with reduced daily physical activity in COPD.
Therefore, the purpose of the present study was to investigate whether patients with COPD and reduced daily physical activity, in addition to ventilatory and peripheral muscle abnormalities, also experience restrictions of the capacity to systematically transport and enhance oxygen availability at the level of peripheral muscles.
To accomplish our goal we performed measurements of quadriceps muscle oxygen availability and central hemodynamic responses in patients with COPD walking on a treadmill at a speed corresponding to their individual mean intensity of daily walking, which was captured by an accelerometer during a period of 7 preceding consecutive days. It was reasoned that in addition to abnormal pulmonary function and peripheral muscle weakness, a restriction dominating central hemodynamic, oxygen transport, and peripheral muscle oxygen availability would be pertinent to those patients with COPD demonstrating reduced levels of physical activity.
MATERIALS AND METHODS

Study Group
Nineteen clinically stable patients with COPD classified by GOLD (19) as stages II (n ϭ 8) and III (n ϭ 11) were recruited for the study according to the following inclusion criteria: 1) a postbronchodilator forced expiratory volume in 1 s (FEV 1) Ͻ70% predicted without significant reversibility (Ͻ12% change in the initial FEV1 value or Ͻ200 ml); and 2) optimal medical therapy for at least 8 wk with no change (37) . Patients had a history compatible with COPD; that is, at least 10 pack years of smoking history. Exclusion criteria included 1) orthopedic, neurologic, and other pathologic conditions or severe pain syndromes that could interfere with physical activity or impair normal movement patterns; 2) respiratory diseases other than COPD (e.g., asthma); 3) clinical signs of acute heart failure, or known unstable or moderate-severe heart disease (arrhythmia, ischemic heart disease, or cardiomyopathy); 4) engagement in any exercise-training program in the last 3 mo; 5) any hospital admission or COPD exacerbations within the previous 4 wk; and 6) inability to participate in at least 5 valid days of activity monitoring measurements. All participants were informed of any risks and discomfort associated with the study, and written informed consent was obtained. The study was approved by the University Hospital Ethics Committee (protocol number 18367).
Preliminary Assessment
All patients underwent the following baseline measurements: anthropometric indices; arterial blood gas parameters; pulmonary function parameters; 6-min walking distance; quadriceps muscle strength; COPD-specific health-related quality of life questionnaires; and the modified Medical Research Council (MMRC) dyspnea scale. Specifically, body weight was measured to the nearest 0.1 kg with a digital scale, and height was measured to the nearest 0.5 cm with a stadiometer. Body mass index was calculated as the ratio of weight (in kilograms) to height (in meters) squared. Body composition was estimated with a bioelectric impedance device (Maltron BF 907; Essex, UK). Fat-free mass (FFM) index was obtained by dividing FFM in kilograms by height. Radial arterial tensions of O 2 (PaO 2 ) and CO2 (PaCO 2 ) and arterial oxygen saturation (%SaO 2 ) were measured from 2-ml blood samples using a blood gas analyzer combined with a co-oximeter (ABL 625; Radiometer, Copenhagen, Denmark) within a few seconds of collection. Spirometry and single-breath transfer factor for carbon dioxide was measured according to American Thoracic Society (ATS)/European Respiratory Society standards (28) after administering 400 g of salbutamol. Postbronchodilator static lung volumes were assessed using a body-box (whole body plethysmography). A 6-min walking test (6MWT) was performed twice according to ATS guidelines (2) , and the greater covered distance was considered for the analysis. Quadriceps muscle strength was assessed using the maximal isometric voluntary contraction technique of the knee extensors following a standardized protocol (43) . The St. George's Respiratory Questionnaire (SGRQ) (23) was employed.
Study Design
Experiments were performed in three visits. During visit 1, patients performed a preliminary incremental exercise protocol on a treadmill (Track Motion, Kettler, Germany). During this protocol, minute-byminute walking intensity, expressed in m/s 2 , was measured with a triaxial accelerometer (DynaPort MoveMonitor; McRoberts, The Hague, The Netherlands) (33, 37, 44). During visit 2, patients were fitted with accelerometers to wear over 7 consecutive days to assess mean walking intensity for each individual patient. During visit 3, patients underwent an individualized walking protocol on the treadmill. The speed on the treadmill was individualized for each patient and corresponded to the mean walking intensity recorded for each patient over the 7 preceding consecutive days of monitoring.
Physical Activity Monitoring
Assessment 1: incremental treadmill walking. Walking intensity during the preliminary treadmill protocol (visit 1) was retrieved from the accelerometer, analyzed minute-by-minute, and mean walking intensity was calculated for each speed. During this protocol, the speed started at 1.4 km/h and increased every 3 min by 0.8 km/h. Assessment 2: outdoor walking monitoring. For visit 2, patients visited the hospital to be equipped with the accelerometer (DynaPort MoveMonitor). Previous studies have shown that this particular activity monitor has been reliably validated against indirect calorimetry, the double-labeled water method, and video recording for patients with COPD in terms of energy expenditure, walking movement intensity, and time spent on different daily living activities (33, 37, 44) . The DynaPort consists of a small, lightweight case (85 ϫ 58 ϫ 11.5 mm, 55 g) containing a triaxial accelerometer, a rechargeable battery (lithium polymer, 204 h in data storage mode), a USB connection, and raw data storage on a MicroSD card. The accelerometer is attached to an elastic strap and positioned on the lower back at the height of the second lumbar vertebra (which was used as an approximation of the body's center of mass). The movement intensity in gravity units (g) is derived from the acceleration signal and gives an indication of the power of the movements. For readership purposes, movement intensity in terms of gravity units provided by the accelerometer was converted to m/s 2 by multiplying by 9.81 (standard acceleration of an object in a vacuum near the surface of the Earth).
Previous published studies using physical activity monitoring systems have revealed that 2 to 7 days of assessment are adequate for measuring physical activity in patients with COPD (10, 32, 34, 38, 40, 41) . On the basis of these findings physical activity was measured over 7 consecutive days (2 weekend days and 5 weekdays). All patients wore the devices for at least 12 h upon waking and removed it when they retired to bed. The mean walking intensity of each individual patient for the 7 days of monitoring expressed in m/s 2 was considered for the treadmill test in visit 3. A measurement of daily physical activity was considered valid if the patient had worn the activity monitor for at least 5 days including weekends for at least 12 h per day. The main reason why we performed only daytime measurement instead of 24-h measurements was that a previous pilot study in patients with COPD (36) showed the period between 24:00 and 08:00 h consists almost entirely of laying-down time. Therefore, assessment after 20:00 h added very little to the overall activity assessed during the first 12 h of the day. All patients were carefully instructed on how the device should be positioned, and they received a manual with clear instructions. Subjects were instructed to keep their daily activity unchanged while wearing the device.
Assessment 3: treadmill walking at individualized speed. Within 72 h after the end of the monitoring period, patients visited the hospital (visit 3) for an individualized speed protocol on the treadmill. During this assessment patients walked for 4 min at the predetermined speed captured during assessment 2 (i.e., at the individual patient's intensity). Prior to imposing the predetermined intensity, patients stood on the treadmill for 4 min for baseline measurements and then warmed up at a speed corresponding to 1.4 km/h for 4 min. All data acquired during the last minute of the individualized speed protocol on the treadmill was considered for the analysis.
Oxygen uptake, pulmonary gas exchange, and ventilatory variables were recorded breath-by-breath (Vmax 229; Sensor Medics). During the test, at rest and at the last minute of exercise, patients performed two inspiratory maneuvers to record the inspiratory capacity to iden-tify the magnitude of dynamic lung hyperinflation during exercise. Percentage of arterial oxygen saturation (%SpO 2) was measured by pulse oxymetry (Nonin 8600; Nonin Medical, North Plymouth, MN). Heart rate was determined using the R-R interval from a 12-lead electrocardiogram. Subjects were also asked to rate their shortness of breath every minute using the 0 -10 Borg's category-ratio scale (4). Cardiac output was recorded via a portable cardiographic conduction devise (PhysioFlow, Enduro; Manatec Biomedical, Macheren, France) (8) . Near-infrared spectroscopy (NIRO 200; Hamamatsu Photonics, Hamamatsu, Japan) was employed to continuously record changes from baseline in quadriceps muscle fractional oxygen saturation (%StO 2) as an indicator of quadriceps muscle oxygen availability (11) (12) (13) 20) . Estimated systemic oxygen delivery was calculated as the product of cardiac output and arterial oxygen content; the latter was calculated as the product of 1.39 ϫ hemoglobin concentration [Hb] and %SpO 2 (5), whereas the difference in arterio-venous oxygen content (a-vO2) was calculated by dividing oxygen uptake by cardiac output. The oxygen extraction ratio was calculated as the ratio of the arterio-venous oxygen content (a-vO 2) difference to arterial oxygen content. In addition, systemic vascular conductance was calculated by dividing cardiac output with mean arterial blood pressure.
Central Hemodynamics
Cardiac output was measured noninvasively throughout the exercise protocol on a treadmill using a portable impedance cardiography device (PhysioFlow). In patients with COPD cardiac output measured at rest and during low-intensity exercise by the PhysioFlow was not affected by the level of thoracic hyperinflation, whereas it exhibited very good agreement with other relevant techniques that directly measure cardiac output by the Fick method (8) . The PhysioFlow principle is based on the assumption that variations in impedance to a high-frequency (75kHz), low-magnitude (1.8 mA) alternating current across the thorax during cardiac ejection result in a waveform from which stroke volume (SV) can be calculated. Initially, an SV index (SVI) is calculated at rest by evaluating 24 consecutive heart beats (autocalibration procedure) using the largest impedance difference during systole, the largest rate of change in the impedance signal (contractility index), the thoracic fluid inversion time, heart rate, and the pulse pressure (systolic minus diastolic arterial pressure). Cardiac output is then calculated by multiplying the SVI by body surface area and HR [R-R interval determined on the electrocardiographic (ECG) first derivative]. The system was autocalibrated before exercise tests on the treadmill. Signal quality was verified by visualizing the ECG tracing and its first derivative (dECG/dt) and the impedance waveform (⌬Z) with its first derivative (dZ/dt). If unstable signal recording occurred, the system did not allow the test to proceed, and a new calibration was performed. After shaving and cleaning the skin, two pairs of electrodes were firmly positioned at the left base of the neck and over the dorsal column at the xiphoid level for transmitting and receiving electrical currents. Two electrodes were also placed on the chest (V1/V6 position) for the ECG signal. The auto calibration procedure was started after a period of at least 5 min during which patients were sitting immobile on a chair. Cardiac output values were stored beat-by-beat.
Quadriceps Muscle Oxygenation by Near-Infrared Spectroscopy
To measure quadriceps muscle oxygenation, one set of nearinfrared spectroscopy (NIRS) optodes were placed on the skin over the left vastus lateralis muscle 10 -12 cm above the knee, secured using double sided adhesive tape. The optode separation distance was 4 cm, corresponding to a penetration depth of ϳ2 cm. Optodes were connected to a NIRO 200 spectrophotometer (Hamamatsu Photonics). The theory of NIRS has been described in detail elsewhere (14) . Briefly, one fiber optic bundle carries the near-infrared light produced by the laser diodes to the tissue of interest, and a second fiber optic bundle returns the transmitted light from the tissue to a photon detector in the spectrometer. The intensity of incident and transmitted light was recorded continuously and, along with the relevant specific extinction coefficients, was used to measure changes in the oxygenation status of hemoglobin ϩ myoglobin (Hb ϩ Mb) and then covered with an optically dense, black vinyl sheet, thus minimizing the intrusion of extraneous light and loss of near-infrared light (9) . The variables assessed by NIRS were the concentration changes of oxygenated, deoxygenated, and total Hb. A commonly derived parameter from NIRS studies in humans is tissue O 2 saturation (StO2; i.e., the ratio of oxygenated Hb to total Hb), which is commonly adopted as an index of tissue oxygen availability reflecting the balance between muscle oxygen supply and demand (11-13, 20, 24) .
Statistical Analysis
Data are reported as mean Ϯ SD. Normal distribution was assessed using the Shapiro-Wilk test revealing that all data were normally distributed. Pearson correlation coefficient analysis was performed to determine the relationship between mean walking intensity and anthropometric, lung function, metabolic, respiratory, central hemodynamic, and systemic and peripheral muscle oxygenation variables and parameters that were recorded during the treadmill test in visit 3. In addition, central hemodynamic and systemic and peripheral muscle oxygenation parameters were evaluated as the change from baseline to the last minute of the treadmill exercise in visit 3. Due to the large number of variables compared/correlated, a Bonferroni-type adjustment was carried out using the Holmes procedure (22) . The P values reported pertain to the variables that remained statistically significant after the Bonferroni-type adjustment. The strongest significant contributors to walking intensity were selected by stepwise multiple regression analyses to identify independent determinants of physical activity. These analyses were performed for all significant baseline clinical and functional variables and for all significant ventilatory function, central hemodynamic, and systemic and peripheral muscle oxygenation variables during treadmill exercise. Using the median walking intensity, the patients were divided into two groups: those who were above and those who were below this critical intensity. Accordingly, a nonparametric test, the Mann-Whitney U-test, was used to identify significant differences in physiological variables between these two groups, and data for each group are reported as median and interquartile ranges (first and third quartiles). The minimum sample size was calculated on the basis of 80% power and a two-sided 0.05 significance level. Sample size capable of detecting a relationship with r ϭ 0.60 between walking intensity and functional changes in central and peripheral hemodynamics and oxygen transport in patients with COPD was estimated on the basis of data from previous studies (37, 44) . The critical sample size was estimated to be 19 patients. Data were analyzed using the SPSS statistical program, version 18 (SPSS, Chicago, IL). The level of significance for was set at P Ͻ 0.05.
RESULTS
Patient Characteristics and Functional Capacity
Patients had normal body mass index without occurrence of muscle wasting, as defined by fat-free mass index (Table 1) . In addition, patients had moderate to severe airway obstruction with increased static lung volumes, substantial reductions in carbon monoxide diffusion capacity, and moderately reduced resting arterial oxygen tension (Table 2) .
Physical Activity Monitoring
Patients with COPD who participated in the study exhibited high compliance with the activity monitoring tasks that were presented because all of them had 7 valid days of measure- Walking speed was highly correlated (r ϭ 0.98, P Ͻ 0.001) with walking intensity during the preliminary incremental treadmill protocol (Fig. 1A) . Furthermore, the mean walking intensity was successfully reproduced for each patient during the individualized speed protocol because there was a linear relationship (r ϭ 0.96, P Ͻ 0.001) between treadmill walking intensity and mean walking intensity monitored over the 7 consecutive days with values being very close to the line of identity (Fig. 1B) . Accordingly, the mean walking time outdoors for the 19 patients during the 7-day period of monitoring was 69 Ϯ 29 min per day ( Table 3 ). The treadmill speed reproducing the aforementioned mean intensity during the individual speed protocol was 3.5 Ϯ 0.8 km/h (Table 3 ). All significant correlations between mean walking intensity and baseline pulmonary function data and quadriceps force are shown in Table 4 .
Physical Activity and Central Hemodynamic Variables
Cardiac output, systemic vascular conductance, and systemic oxygen delivery measured during the treadmill exercise were significantly (P Ͻ 0.05) greater in those patients exhib- Values are expressed as means Ϯ SD for 19 subjects. FEV1, forced expiratory volume in one second; FVC, forced vital capacity; SVC, slow vital capacity; IC, inspiratory capacity; TLC, total lung capacity; RV, residual volume; FRC, functional residual capacity (assumed from intrathoracic gas volume); TLCO, diffusing capacity of the lung for carbon monoxide; PaO2, partial pressure of arterial oxygen; PaCO2, partial pressure of arterial carbon dioxide; SaO2, arterial oxygen saturation. iting a high walking intensity compared with those exhibiting a lower intensity (Table 3 ). Figure 2 shows the relationship between daily physical activity in terms of walking intensity with measures of central hemodynamic responses. Specifically, there was a significant correlation between walking intensity and changes from baseline in cardiac output (r ϭ 0.73, P Ͻ 0.001) ( Fig. 2A) during the individualized speed treadmill protocol, indicating that those patients exhibiting greater changes in cardiac output from baseline during treadmill walking also had greater mean walking intensity during the 7-day monitoring period. In addition, the association between stroke volume and walking intensity (r ϭ 0.72, P Ͻ 0.001) was more profound than that of heart frequency and walking intensity (r ϭ 0.46, P ϭ 0.049). Furthermore, a moderately strong correlation was found between individualized walking intensity and changes from baseline in systemic vascular conductance (r ϭ 0.77, P Ͻ 0.001) and systemic oxygen delivery (r ϭ 0.70, P ϭ 0.001) (Fig. 2 , B and C) with the patients exhibiting greater increases in systemic vascular conductance and systemic oxygen delivery being those also exhibiting greater walking intensity during daily life. Interestingly, there was no significant relationship (P Ͼ 0.05) between walking intensity during the 7-day monitoring period and baseline hemodynamic and systemic oxygen availability data (Table 5) . Values are expressed as means Ϯ SD or median and interquartile range (first and third quartile). Each patient's mean walking intensity was monitored during 7 days, and was reproduced on a treadmill. The presented variables are those measured at the last minute of a 4-min walking on the treadmill at the predetermined speed reproducing each patient's mean walking intensity. VO2, oxygen uptake; VE/MVV, ratio of minute ventilation over maximal voluntary ventilation; HR, hear; SpO2, arterial oxygen saturation measured by pulse oxymetry; a-vO2 difference, arterio-venous oxygen content difference; StO2, quadriceps muscle fractional oxygen saturation. *Significant differences between the two groups, P Ͻ 0.05. 
Physical Activity, and Systemic and Quadriceps Muscle Oxygenation Variables
Percentage of arterial oxygen saturation (%SpO 2 ) and quadriceps muscle %StO 2 , and differences in arterio-venous oxygen content (a-vO 2 ) measured during the treadmill exercise were all significantly different (P Ͻ 0.05) between those patients exhibiting a high walking intensity and those exhibiting a lower intensity (Table 3 ). Figure 3 shows the relationship between daily physical activity in terms of walking intensity and variables reflecting the regulation of systemic and peripheral muscle oxygen availability. Accordingly, a significant relationship was detected between walking intensity and changes from baseline in pulse-oxymetry saturation (r ϭ 0.68, P ϭ 0.001) (Fig. 3A) with the patients becoming more hypoxemic during the individualized speed treadmill protocol exhibiting lower levels of walking intensity. Furthermore, there was a moderately strong relationship between intensity of daily walking and changes from baseline in quadriceps muscle %StO 2 (r ϭ 0.77, P Ͻ 0.001) (Fig. 3B) with those patients exhibiting greater walking intensity also demonstrating more profound increases in quadriceps muscle fractional oxygen saturation at the individualized walking speed. Consequently, an inverse relationship was found between individualized walking intensity (Fig. 3C ) and changes from baseline in a-vO 2 difference (r ϭ Ϫ0.73, P Ͻ 0.001) with the patients exhibiting greater increases in a-vO 2 difference being those also exhibiting lower walking intensity during daily life. Interestingly, there was no significant relationship (P Ͼ 0.05) between walking intensity during the 7-day monitoring period and systemic and quadriceps muscle oxygenation variables at baseline (Table 5) . Table 6 shows the relationships between quadriceps muscle %StO 2 and variables that regulate oxygen transport during the individualized speed treadmill protocol. Specifically, there were significant (P Ͻ 0.05) positive relationships between changes from baseline (rest) in cardiac output, systemic vascular conductance, systemic oxygen delivery, and %SpO 2 , and changes from baseline in %StO 2 . Because %StO 2 is often taken as an index of muscle oxygen availability (11) (12) (13) 20) , the aforementioned relationships indicate that patients exhibiting greater increases in quadriceps muscle oxygen availability also demonstrated greater increases in variables that regulate oxygen transport. Interestingly, there was also a significant (P Ͻ 0.001) negative relationship between changes from baseline in a-vO 2 difference and changes in quadriceps muscle %StO 2 (Table 6) .
Quadriceps Muscle Oxygen Availability and Oxygen Transport
Multiple Regression Analyses
The stepwise multiple regression analysis model including all significant clinical and pulmonary function variables (Table  4) retained only diffusion capacity (r ϭ 0.75, P Ͻ 0.001), slow vital capacity (r change ϭ 0.11, P ϭ 0.005), and age (r change ϭ 0.05, P ϭ 0.018) as the significant best three contributors to walking intensity. The aforementioned model accounted for 82% of the explained variance in walking intensity. In addition, the stepwise multiple regression analysis model including all significant ventilatory, central hemody- namic, and systemic and peripheral muscle oxygenation variables during exercise retained changes only in %StO 2 (r ϭ 0.77, P ϭ 0.005) and cardiac output (r change ϭ 0.08, P ϭ 0.020) as the significant best two contributors to walking intensity. The aforementioned model accounted for 72% of the explained variance for walking intensity.
DISCUSSION
In patients with COPD, reduced daily physical activity has been partially explained by the development of dynamic lung hyperinflation, independent of the degree of disease severity (18) . In this context it was reasoned that other known pathophysiological factors limiting exercise tolerance in COPD; namely, the adverse hemodynamic response caused by impaired lung mechanics, the reduced arterial oxygen content, and the degree of peripheral muscle dysfunction and wasting (39 -46) might also adversely affect daily physical activity in patients with COPD.
The present study demonstrates that besides the extend of pulmonary malfunction and muscle weakness, and the degree of ventilatory limitation (18, 21, 31, 34, 39, 49) (Table 4) , cardiac output, systemic oxygen delivery, and quadriceps muscle oxygen availability (Figs. 2 and 3 ) are significantly associated with reduced intensity of walking during daily life in patients with COPD.
Furthermore, this study illustrates that in relation to patients exhibiting greater intensity of daily walking, patients with a lower intensity of daily walking experienced diminished central hemodynamic and peripheral muscle oxygenation capacities, and a more profound reduction in %SpO 2 (Table 3 , Figs.  2 and 3) . The novelty of the present investigation derives from the fact that each individual patient's actual walking intensity was reproduced on a treadmill indoors, thereby allowing simultaneous measurements of central hemodynamic, and systemic and peripheral muscle oxygen availability variables across a wide range of COPD severity.
Walking intensity is an important aspect of physical activity behavior that a patient with COPD adopts in daily living. Numerous recent studies have emphasized the finding that the intensity of movement adopted by patients with COPD during walking is reduced by an average of 17 to 33% compared with that in healthy, age-matched individuals (10, 21, 32, 34, 48 ) and typically corresponds with 1.8 m/s 2 in patients with COPD in GOLD stages II and III (32, 34) . In the present study, the average intensity of walking for the 19 patients was 1.8 Ϯ 0.3 m/s 2 (Table 3) [i.e., similar to that typically exhibited by patients with COPD in GOLD stages II and III (32, 34) ]. Accordingly, in the present study we used the median walking intensity (1.88 m/s 2 ) to differentiate patients with lower from those with higher walking intensity. Furthermore, it was shown that patients who exhibited a higher walking intensity demonstrated significantly greater central hemodynamic, and systemic and local muscle oxygen saturation responses than patients who exhibited lower walking intensities (Table 3) . However, in the present study we found that the walking duration during the 7 days of monitoring was 69 Ϯ 29 min per day ( Table 3 ), indicating that our patients appeared to be more active compared with previous groups of patients with COPD who have been studied (21, 32, 34) .
Along these lines, patients who exhibited greater walking intensity during the 7-day period of monitoring also exhibited greater increases in cardiac output during indoor walking at an individualized treadmill speed ( Fig. 2A) , most likely reflecting better cardiovascular fitness (45) . In support of this notion the association between stroke volume and walking intensity (r ϭ 0.72) was more profound than that of heart frequency and walking intensity (r ϭ 0.46). These findings corroborate those by Watz and colleagues (49) showing that reduced levels of daily physical activity recorded in patients with COPD are associated with a diminished resting-filling process of the left ventricle and left cardiac dysfunction. Furthermore, taking into account that a reduction from baseline in %SpO 2 (Fig. 3A) was also more profound in those patients exhibiting lower walking intensities, it becomes apparent that systemic oxygen delivery is an important physiological factor regulating the walking intensity of daily activities (Fig. 2C) . In support of this notion is evidence that in patients with COPD, mechanisms that involve oxygen transport are frequently impaired as a result of reduced cardiovascular function (48) . Specifically, coexisting right or left ventricle dysfunction can impair exercise simply because of cardiac dysfunction, which often leads to impaired oxygen availability and early development of metabolic acidosis (30) . Furthermore, functionally important arrhythmias may also impair the normal increase in cardiac output as a function of increase in work rate (15, 29) . One could argue that the restrained increase in cardiac output could be the result of reduced walking intensity secondary to ventilatory limitations and/or peripheral muscle weakness, and not the cause of reduced walking intensity. However, the greater a-vO 2 difference exhibited by patients experiencing lower walking intensities and cardiac outputs provides evidence for a physiological mechanism that counteracts the limited increase in cardiac output by increasing fractional oxygen extraction and thus muscle oxygen availability (Table 3) .
Another important finding of the present study is the limited ability to enhance locomotor muscle oxygen availability during treadmill walking in patients with lower walking intensities. This finding becomes apparent by the significant correlation (r ϭ 0.77) between changes from baseline in quadriceps muscle %StO 2 and walking intensity adopted by each individual patient (Fig. 3B) . A potential explanation for this finding is in turn provided by the significant correlation between the changes from baseline in cardiac output, %SpO 2 , and systemic oxygen delivery, and changes in quadriceps muscle %StO 2 SpO2, arterial oxygen saturation measured by pulse oxymetry; a-vO2 difference, arterio-venous oxygen content difference. *Measured at the last minute of a 4-minute walking on the treadmill compared with baseline (rest). (Table 6) , thereby suggesting that patients with a greater capacity to enhance systemic oxygen transport were also those who were able to increase local muscle oxygen availability/saturation, thus sustaining greater walking intensity (Table 6 ). In support of this suggestion, changes in cardiac output and %StO 2 emerged as the best two contributors to walking intensity.
Factors determining local muscle %StO 2 are modulated by the rate of oxygen delivery and oxygen extraction (11) (12) (13) 20) . The former factor was compromised in patients exhibiting lower walking intensity (Tables 3 and 6 ), whereas oxygen extraction and a-vO 2 difference was increased in these patients (Fig. 3C, Table 3 ), most likely in an attempt to compensate for reduced systemic oxygen delivery (Fig. 2C) .
The results of the present study corroborate previous findings (3, 18, 21, 31, 34, 39, 41) by showing significant associations between daily physical activity and variables such as age, lung diffusion capacity, 6-min walk distance, quadriceps muscle strength and MMRC dyspnea score, and the magnitude of resting lung hyperinflation ( Table 4 ). The present study, however, expands previous findings by demonstrating that among pulmonary function variables, lung diffusion capacity and slow vital capacity emerge as the best two contributors to walking intensity, thereby strengthening the notion that the degree of baseline pulmonary dysfunction importantly contributes to reduced daily physical activity (18, 21, 31, 34, 39, 49) . Patients who are incapable of adopting greater walking intensities than average previously indicated (32, 34) and confirmed in the present study (i.e., 1.88 m/s 2 ), demonstrate compromised physiological function not only at the level of respiratory function and peripheral muscles, but also at different system levels; namely, central and peripheral hemodynamic regulations. Thus therapeutic interventions whose aim is to increase the capacity of the body to transport and utilize oxygen, such as rehabilitative exercise training, are justified in promoting enhanced daily activity levels, as has been previously reported by others (27, 32, 38) .
There are potential limitations to the present study. The sample size of patients with COPD may limit generalization of the results to the entire COPD patient population. Another potential limitation is that the study group consisted mostly of men. Furthermore, we did not include patients with GOLD stages I and IV and thus have the ability to link the magnitude of compromised physiological responses relative to physical exertion across the whole range of disease severity. Study of a control, age-matched group would have allowed us to identify the extent to which the different physiological systems limit daily physical activity. In addition, we focused our evaluation on the oxygenation profile in a specific region of vastus lateralis muscle during exercise, which does not provide a comprehensive evaluation of the whole quadriceps muscle oxygenation response to exercise. Finally, another potential limitation is that the present study was cross-sectional and thus we cannot establish a causal relationship, but only one of association.
In conclusion, in patients with COPD, in addition to pulmonary restrictions and peripheral muscle weakness, walking intensity, which commonly reflects daily physical activity, is associated with central hemodynamic and peripheral muscle oxygenation adaptations that regulate oxygen transport and peripheral muscle oxygen availability. Interventions that aim to enhance oxygen transport and utilization during physical exertion in these patients would be expected to be accompanied by improved intensity of physical activity.
